Chien‐Ning Huang

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff et al. · The Lancet · 2023 · 590 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +6

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan

Yi‐Jing Sheen, Chih‐Cheng Hsu, Yi‐Der Jiang et al. · Journal of the Formosan Medical Association · 2019 · 168 citations · Full text

<i>Hibiscus sabdariffa</i> Polyphenolic Extract Inhibits Hyperglycemia, Hyperlipidemia, and Glycation-Oxidative Stress while Improving Insulin Resistance

Chiung‐Huei Peng, Charng-Cherng Chyau, Kuei‐Chuan Chan et al. · Journal of Agricultural and Food Chemistry · 2011 · 164 citations

Polyphenolic Extract, Insulin Signaling, Polyphenolics +16